Eko Health, a developer of technology to detect heart and lung disease remotely, raised a $41 million Series D, CEO Connor Landgraf tells Axios exclusively.
Why it matters: Eko aims to enable a wide range of providers to spot heart and lung abnormalities faster and more easily.
